MedTrace Logo

The Prospective Segeberg TAVI Registry

NCT03192774 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-06-06

No results posted yet for this study

Summary

A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany

Conditions

  • Aortic Valve Stenosis

Interventions

DEVICE

Transcatheter Aortic Valve Implantation

Interventional replacement of the aortic valve

Sponsors & Collaborators

  • Segeberger Kliniken GmbH

    lead OTHER

Principal Investigators

  • Gert Richardt, MD · Heart Center, Segeberger Kliniken

  • Mohamed Abdel-Wahab, MD · Heart Center, Segeberger Kliniken

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2022-12-31
Completion
2032-12-31
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03192774 on ClinicalTrials.gov